Annual Cash & Cash Equivalents
$49.26 M
+$3.34 M+7.27%
December 31, 2023
Summary
- As of February 8, 2025, ELEV annual cash & cash equivalents is $49.26 million, with the most recent change of +$3.34 million (+7.27%) on December 31, 2023.
- During the last 3 years, ELEV annual cash & cash equivalents has fallen by -$30.14 million (-37.97%).
- ELEV annual cash & cash equivalents is now -66.33% below its all-time high of $146.28 million, reached on December 31, 2021.
Performance
ELEV Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$48.20 M
-$11.24 M-18.92%
September 30, 2024
Summary
- As of February 8, 2025, ELEV quarterly cash and cash equivalents is $48.20 million, with the most recent change of -$11.24 million (-18.92%) on September 30, 2024.
- Over the past year, ELEV quarterly cash and cash equivalents has stayed the same.
- ELEV quarterly cash and cash equivalents is now -69.50% below its all-time high of $158.02 million, reached on June 30, 2021.
Performance
ELEV Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
ELEV Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +7.3% | 0.0% |
| 3 y3 years | -38.0% | +5.0% |
| 5 y5 years | +2730.8% | +5.0% |
ELEV Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -66.3% | +7.3% | -67.0% | +5.0% |
| 5 y | 5-year | -66.3% | +2730.8% | -69.5% | +5.0% |
| alltime | all time | -66.3% | +2730.8% | -69.5% | +5.0% |
Elevation Oncology Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $48.20 M(-18.9%) |
| Jun 2024 | - | $59.45 M(-34.4%) |
| Mar 2024 | - | $90.63 M(+84.0%) |
| Dec 2023 | $49.26 M(+7.3%) | $49.26 M(-10.2%) |
| Sep 2023 | - | $54.88 M(-48.4%) |
| Jun 2023 | - | $106.33 M(+90.2%) |
| Mar 2023 | - | $55.90 M(+21.7%) |
| Dec 2022 | $45.92 M | $45.92 M(-12.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $52.59 M(-2.4%) |
| Jun 2022 | - | $53.88 M(+1.6%) |
| Mar 2022 | - | $53.01 M(-63.8%) |
| Dec 2021 | $146.28 M(+84.2%) | $146.28 M(-5.7%) |
| Sep 2021 | - | $155.20 M(-1.8%) |
| Jun 2021 | - | $158.02 M(+126.0%) |
| Mar 2021 | - | $69.91 M(-11.9%) |
| Dec 2020 | $79.40 M(+4463.2%) | $79.40 M |
| Dec 2019 | $1.74 M | - |
FAQ
- What is Elevation Oncology annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Elevation Oncology?
- What is Elevation Oncology annual cash & cash equivalents year-on-year change?
- What is Elevation Oncology quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Elevation Oncology?
- What is Elevation Oncology quarterly cash and cash equivalents year-on-year change?
What is Elevation Oncology annual cash & cash equivalents?
The current annual cash & cash equivalents of ELEV is $49.26 M
What is the all time high annual cash & cash equivalents for Elevation Oncology?
Elevation Oncology all-time high annual cash & cash equivalents is $146.28 M
What is Elevation Oncology annual cash & cash equivalents year-on-year change?
Over the past year, ELEV annual cash & cash equivalents has changed by +$3.34 M (+7.27%)
What is Elevation Oncology quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of ELEV is $48.20 M
What is the all time high quarterly cash and cash equivalents for Elevation Oncology?
Elevation Oncology all-time high quarterly cash and cash equivalents is $158.02 M
What is Elevation Oncology quarterly cash and cash equivalents year-on-year change?
Over the past year, ELEV quarterly cash and cash equivalents has changed by $0.00 (0.00%)